Home » Stocks » RCHR

ArcherDX, Inc. (RCHR)

ArcherDX was planning to go public, but the IPO has been withdrawn.
Stock Price: Pending
IPO price not available yet
Market Cap n/a
Revenue (ttm) 55.91M
Net Income (ttm) n/a
Shares Out n/a
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day n/a
Last Price n/a
Previous Close n/a
Change ($) n/a
Change (%) n/a
Day's Open n/a
Day's Range n/a
Day's Volume n/a
52-Week Range n/a

News

There are no news available yet.

About RCHR

ArcherDX is a leading genomics company democratizing precision oncology. We offer a suite of products and services that are highly accurate, personal, actionable and easy to use in local settings. This empowers clinicians to control the sample, data, patient care and economics. Additionally, our products and services enable biopharmaceutical companies to cost-effectively accelerate drug development. We believe these benefits will drive broader adoption of precision oncology throughout the therapeutic continuum, improving patient care. Our produ... [Read more...]

IPO Date
Withdrawn
CEO
Jason Myers
Employees
337
Stock Exchange
NASDAQ
Ticker Symbol
RCHR
Full Company Profile